Table 4 Effects of OEO, main components at different concentrations (5 and 10 µg/ml), and positive control (L-NAME, 1.3 μg/ml) on NO production and NOS activity in LPS-stimulated macrophages.
Treatment | NO | NOS activity |
|---|---|---|
Control | 27.0 ± 1.22de | 13.3 ± 0.60a |
LPS | 38.0 ± 2.13g | 42.3 ± 2.37f |
LPS/L-Name1.3 | 21.0 ± 1.22c | 17.3 ± 1.00b |
LPS/OEO5 | 21.3 ± 1.26c | 31.7 ± 1.87cd |
LPS/OEO10 | 14.7 ± 0.84a | 17.6 ± 1.00b |
LPS/Thymol5 | 25.6 ± 1.41d | 28.3 ± 1.56c |
LPS/Thymol10 | 18.0 ± 1.04b | 17.3 ± 1.00b |
LPS/Carvacrol5 | 21.7 ± 1.17d | 19.0 ± 1.03b |
LPS/Carvacrol10 | 12.0 ± 0.70a | 11.3 ± 0.66a |
LPS/Cymene5 | 29.0 ± 1.51e | 38.7 ± 2.01ef |
LPS/Cymene10 | 24.7 ± 1.33d | 32.7 ± 1.77d |
LPS/Terpinene5 | 32.7 ± 1.87f | 36.7 ± 2.13e |
LPS/Terpinene10 | 28.0 ± 1.43e | 33.6 ± 1.71de |